Loading…
← CockpitCompetitor Analysis › 603363.SS Fujian Aonong Biological Technology Group Incorporation Limited Class AOpen in the cockpit ↗

Fujian Aonong Biological Technology Group Incorporation Limited Class A603363.SSCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Agricultural Commodities/Milling

Fujian-based hog farming and animal-feed company.

Momentum neutral 58
Mkt cap
$1.09B
US dollars, full cap
Free float
59%
of shares outstanding
$/day
$7.56M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-10.2 pp
WACC 5.0%
Hurdle
n/a
no reverse DCF
Next earnings
171 days
26 Apr 2027
Close · CNYCN¥2.69
1D0.0%
1W+5.1%
1M-3.2%
3M-5.6%
6M-20.6%
YTD-41.6%
1Y-46.1%
ATR %2.9%
52w lowhigh54.5% off high

What Fujian Aonong Biological Technology Group Incorporation does

Fujian-based hog farming and animal-feed company.

Sells compound feed to farmers and also raises and sells its own pigs, so the pig price cycle decides whether a year is profitable, while feed supplies a steadier but lower-margin sales base.

Products and services

  • Hog farming
  • Compound feed

Customers

  • Food processors/wholesalers

Where it sits in the supply chain

  • Agriculture
  • Animal feed
  • Hog farming

What could go wrong

  • Hog-price cycles

Moat: none. Commodity hog/feed producer subject to price cycles.

Headquarters: Fuzhou, Fujian, China · Employees: 5,126

Named competitors

Fujian Aonong Biological Technology Group Incorporation at a glance

Size Fujian Aonong Biological Technology Group Incorporation (603363.SS) is a China Consumer Staples company (Agricultural Commodities/Milling) with a market value of $1.09B, the 2141st largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥2.69 on 6 Nov 2026.

Performance Over six months the shares fell 20.6%, against -14.2% for the median peer and -16.4% for the China market (cap-weighted) — 9th lowest of 21 in its peer set.

Growth Revenue grew 12.1% over the last twelve months (peer median +1.4%); the operating margin is -8.2% (peer median 3.6%).

Valuation It trades at 1.1× enterprise value to sales against a peer median of 1.5× (6th cheapest of 21).

Capital Return on invested capital runs 10.2 points below its cost of capital (5.0% WACC).

Next results Next results expected around 26 Apr 2027 (exchange calendar; dates can move).

Relative performance

809010011 May 202611 Aug 20266 Nov 2026Peer median 87603363.SS 80
Six months, rebased to 100: Fujian Aonong Biological Technology Group Incorporation against the median of its 20 peers (local-currency closes).

Fujian Aonong Biological Technology Group Incorporation financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥9.16BCN¥8.47BCN¥8.76BCN¥19.5BCN¥21.6B
Revenue growth—-3%-55%-10%—
Gross profitCN¥470MCN¥443M-CN¥57.5M-CN¥1.12BCN¥798M
EBITDAn/aCN¥221M-CN¥518,760-CN¥1.34BCN¥653M
Net income-CN¥728MCN¥77.6MCN¥579M-CN¥3.65B-CN¥1.04B
Free cash flow-CN¥51.5M-CN¥96.5M-CN¥379MCN¥472M-CN¥835M
Capital expenditureCN¥135MCN¥230MCN¥263MCN¥512MCN¥1.50B
Total debtCN¥2.51BCN¥2.37BCN¥2.92BCN¥8.44BCN¥9.55B

Quarterly statements and history in the cockpit →

Fujian Aonong Biological Technology Group Incorporation competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-30%-20%-10%0%-10%0%+10%6002512419AVANTIFEEDAVO603517002041603477MPEKRBLGODREJAGRO600108ELD30018912151210DMCAGROCBO000860000735603363.SS6-month return →1-month return →
Up and to the right = strong over both horizons. Fujian Aonong Biological Technology Group Incorporation is the large dot.

Fundamentals: revenue growth against valuation

-20%-10%0%+10%+20%2×4×6×6002512419AVANTIFEEDAVO603517002041603477MPEKRBLGODREJAGRO600108ELD30018912151210DMCAGROCBO000860000735603363.SSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Fujian Aonong Biological Technology Group Incorporation is the large dot.

Fujian Aonong Biological Technology Group Incorporation competitors and peer comparison

Head to head with its named competitors (603363.SS vs 000876.SZ vs 002714.SZ)
CompanyMarket cap6M returnRevenue growthOp. marginEV / SalesReq g
Fujian Aonong Biological Technology Group Incorporation 603363.SS$1.09B-21%+12%-8%1.1×n/a
New Hope Liuhe 000876.SZ$4.71B-19%+7%-3%0.9×n/a
Muyuan Foods 002714.SZ$33.9B-1%-19%-4%2.2×n/a

How Fujian Aonong Biological Technology Group Incorporation compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Fujian Aonong Biological Technology Group Incorporation against its 20 peers (data as of 6 Nov 2026)
Measure603363.SSPeer medianRank in peer set
1-month return-3.2%-3.4%11th highest of 21
6-month return-20.6%-14.2%9th lowest of 21
Distance from 52-week high-54.5%-28.6%3rd lowest of 21
Revenue growth (TTM)+12.1%+1.4%3rd highest of 21
Operating margin-8.2%3.6%2nd lowest of 21
EV / Sales1.1×1.5×6th cheapest of 21
ROIC minus cost of capital-10.2 pp-2.7 pp3rd lowest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Fujian Aonong Biological Technology Group Incorporation 603363.SSChina$1.09B-21%+12%-8%1.1×n/an/a
Xinjiang Guannong 600251.SSChina$1.09B-27%-32%-4%3.2×n/an/a
Dekon Food And Agriculture 2419.HKHong Kong$1.16B-16%-10%-6%0.5×-5.0%+22.4%
Avanti Feeds AVANTIFEED.NSIndia$1.02B-51%+11%9%1.5×17.1%+8.0%
Mission Produce AVOUnited States$1.02B-11%-6%4%1.1×n/an/a
Juewei Food 603517.SSChina$1.01B-13%-8%3%1.3×n/an/a
Shandong Denghai Seeds 002041.SZChina$1.19B-12%-1%3%4.2×23.5%+4.2%
Leshan Giantstar Farming & Husbandry 603477.SSChina$1.19B-19%-2%-15%1.6×n/an/a
M.P. Evans MPE.LUnited Kingdom$1.20B-5%+1%39%2.8×-9.7%+15.6%
KRBL KRBL.NSIndia$990M+8%0%16%1.0×4.2%+8.8%
Godrej Agrovet GODREJAGRO.NSIndia$1.23B+3%+9%6%1.1×15.1%+10.3%
Gansu Yasheng Industrial (Group) 600108.SSChina$961M-24%-1%2%2.5×n/an/a
Elders ELD.AXAustralia$955M-12%+11%4%0.6×5.6%+8.9%
Hainan Shennong Seed Industry Technology 300189.SZChina$946M-11%+17%4%29.2×n/an/a
Charoen Pokphand Enterprise (Taiwan) 1215.TWTaiwan$927M-26%+4%10%1.6×-1.2%+5.1%
Great Wall Enterprise 1210.TWTaiwan$1.28B-4%+2%4%0.7×n/an/a
Del Monte DMCUnited States$1.29B-27%+1%4%0.4×n/an/a
Adecoagro AGROUnited States$1.30B-31%+7%2%2.2×37.5%+12.1%
Cobram Estate Olives CBO.AXAustralia$896M-29%+11%-5%6.7×n/an/a
Beijing Shunxin Agriculture 000860.SZChina$1.36B-4%-20%-5%1.3×n/an/a
Luoniushan 000735.SZChina$876M-23%+48%-2%2.0×n/an/a

Questions

Who are Fujian Aonong Biological Technology Group Incorporation's main competitors?
Named competitors: New Hope Liuhe (000876.SZ), Muyuan Foods (002714.SZ). The cockpit's measured peer set (industry) also includes Xinjiang Guannong (600251.SS), Dekon Food And Agriculture (2419.HK), Avanti Feeds (AVANTIFEED.NS), Mission Produce (AVO), Juewei Food (603517.SS), Shandong Denghai Seeds (002041.SZ).
Is Fujian Aonong Biological Technology Group Incorporation expensive compared with its peers?
On ev / sales it trades at 1.1× against a peer median of 1.5×, 6th cheapest of 21 in its peer set.
How has Fujian Aonong Biological Technology Group Incorporation stock performed?
Over six months to 6 Nov 2026 the shares returned -20.6% against -14.2% for the median peer; over one year -46.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.